
Antiprotons could help fight against cancer
A pioneering experiment at CERN with potential for cancer therapy has produced its first results.
Thank you for registering
If you'd like to change your details at any time, please visit My account
A pioneering experiment at CERN with potential for cancer therapy has produced its first results.
The Japanese-European ASACUSA team at CERN has measured the antiproton-to-electron-mass ratio to record-breaking accuracy.
Walter Oelert, leader of the team that 10 years ago obtained the first antimatter atoms, talks to Tomasz Rozek about the fact and fiction surrounding the discovery.
It is 50 years since Emilio Segrè, Owen Chamberlain and their group first created an antiproton. Lynn Yarris describes their achievement at Berkeley's Bevatron in 1955.
The latest in the Low Energy Antiproton Physics series of conferences in Bonn showed that this field of research is increasingly vibrant and exciting, as Walter Oelert describes.
A workshop in Japan in the spring looked at how to make and use beams of ultra-slow antiprotons over a wide range of physics.
A new technique for cooling antiprotons has been tested at CERN's Antiproton Decelerator (AD), yielding 50 times more trapped antiprotons per cycle than ever before.
The Balloon-borne Experiment with Superconducting Spectrometer (BESS) launched a cosmic-ray spectrometer from Antarctica on 13 December.
The new method consists of exciting caesium atoms from an oven with two lasers, and then introducing the caesium into a positron trap.
This is an important step towards the goal of producing antihydrogen atoms cold enough – that is, slow enough – for precision spectroscopy.